Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor α 2

Journal of Experimental Medicine

Volumn 197, Issue 6, 2003, Pages 703-709

  Wood, Nancy ^a   Whitters, Matthew J ^a   Jacobson, Bruce A ^a   Witek, JoAnn ^a   Sypek, Joseph P ^a   Kasaian, Marion ^a   Eppihimer, Michael J ^a   Unger, Michelle ^a   Tanaka, Takashi ^b   Goldman, Samuel J ^a   Collins, Mary ^a   Donaldson, Debra D ^a   Grusby, Michael J ^b  

^a PFIZER INC   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Immunoglobulin E; Interleukin 13; Knockout mice; Nitric oxide; Receptors

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 13 RECEPTOR ALPHA2; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 4 RECEPTOR ALPHA; LIPOPOLYSACCHARIDE; NITRIC OXIDE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BONE MARROW CELL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GENE TARGETING; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOREGULATION; INTERFERON PRODUCTION; MACROPHAGE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE IMMUNITY; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; SIGNAL DETECTION; STEM CELL; TUMOR RECURRENCE; WILD TYPE;

ANIMALS; CELLS, CULTURED; FIBROBLASTS; GENE TARGETING; IMMUNOGLOBULINS; INTERFERON TYPE II; INTERLEUKIN-13; INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-13; RECEPTORS, INTERLEUKIN-4; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR; STEM CELLS; TRANS-ACTIVATORS;

EID: 0344091551     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20020906     Document Type: Article

References (38)

1. Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17:255-281.
2. Finkelman, F.D., T.A. Wynn, D.D. Donaldson, and J.F. Urban. 1999. The role of IL-13 in helminth-induced inflammation and protective immunity against nematode infections. Curr. Opin. Immunol. 11:420-426.
3. Urban, J.F., Jr., N. Noben-Trauth, D.D. Donaldson, K.B. Madden, S.C. Morris, M. Collins, and F.D. Finkelman. 1998. IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity. 8:255-264.
4. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T.Y. Neben, C.L. Karp, and D.D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science. 282:2258-2261.
5. Grunig, G., M. Wamock, A.E. Wakil, R. Venkayya, F. Brombacher, D.M. Rennick, D. Sheppard, M. Mohrs, D.D. Donaldson, R.M. Locksley, et al. 1998. Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 282:2261-2263.
6. Chiaramonte, M.G., L.R. Schopf, T.Y. Neben, A.W. Cheever, D.D. Donaldson, and T.A. Wynn. 1999. IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs. J. Immunol. 162:920-930.
7. Caput, D., P. Laurent, M. Kaghad, J.M. Lelias, S. Lefort, N. Vita, and P. Ferrara. 1996. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. J. Biol. Chem. 271:16921-16926.
8. Aman, M.J., N. Tayebi, N.I. Obiri, R.K. Puri, W.S. Modi, and W.J. Leonard. 1996. cDNA cloning and characterization of the human interleukin 13 receptor alpha chain. J. Biol. Chem. 271:29265-29270.
9. Hilton, DJ., J.G. Zhang, D. Metcalf, W.S. Alexander, N.A. Nicola, and T.A. Willson. 1996. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. USA. 93:497-501.
10. Donaldson, D., M. Whitters, L. Fitz, T. Neben, H. Finnerty, S. Henderson, R.M. O'Hara, Jr., D. Beier, K. Turner, C. Wood, et al. 1998. The murine IL-13 receptor α2: molecular cloning, characterization, and comparison with murine IL-13 receptor α1. J. Immunol. 161:2317-2324.
11. Murata, T., J. Taguchi, and R.K. Puri. 1998. Interleukin-13 receptor alpha' but not alpha chain: a functional component of interleukin-4 receptors. Blood. 91:3884-3891.
12. Zurawski, S.M., F. Vega, Jr., B. Huyghe, and G. Zurawski. 1993. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J. 12:2663-2670.
13. Zhang, J.G., DJ. Hilton, T.A. Willson, C. McFarlane, B.A. Roberts, R.L. Moritz, R.J. Simpson, W.S. Alexander, D. Metcalf, and N.A. Nicola. 1997. Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned Il-13 receptor and Il-4 receptor alpha-chains. J. Biol. Chem. 272:9474-9480.
14. Colotta, F., S. Orlando, E.J. Fadlon, S. Sozzani, C. Matteucci, and A. Mantovani. 1995. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells. J. Exp. Med. 181:2181-2186.
15. Doherty, T.M., R. Kastelein, S. Menon, S. Andrade, and R.L. Coffman. 1993. Modulation of murine macrophage function by IL-13. J. Immunol. 151:7151-7160.
16. Bogdan, C., H. Thuring, M. Dlaska, M. Rollinghoff, and G. Weiss. 1997. Mechanism of suppression of macrophage nitric oxide release by IL-13: influence of the macrophage population. J. Immunol. 159:4506-4513.
17. Doyle, A.G., G. Herbein, L.J. Montaner, A.J. Minty, D. Caput, P. Ferrara, and S. Gordon. 1994. Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-gamma. Eur. J. Immunol. 24:1441-1445.
18. Punnonen, J., G. Aversa, B.G. Cocks, A.N. McKenzie, S. Menon, G. Zurawski, R. de Waal Malefyt, and J.E. de Vries. 1993. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA. 90:3730-3734.
19. Lai, Y.H., J.M. Heslan, S. Poppema, J.F. Elliot, and T.R. Mosmann. 1996. Continuous administration of IL-13 to mice induces extramedullary hemopoiesis and monocytosis. J. Immunol. 156:3166-3173.
20. Muchamuel, T., S. Menon, P. Pisacane, M.C. Howard, and D.A. Cockayne. 1997. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with downmodulation of TNF-alpha, IFN-gamma, and IL-12 production. J. Immunol. 158:2898-2903.
21. Nicoletti, F., G. Mancuso, V. Cusumano, R. Di Marco, P. Zaccone, K. Bendtzen, and G. Teti. 1997. Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13. Eur. J. Immunol. 27:1580-1583.
22. Di Santo, E., C. Meazza, M. Sironi, P. Fruscella, A. Mantovani, J.D. Sipe, and P. Ghezzi. 1997. IL-13 inhibits TNF production but potentiates that of IL-6 in vivo and ex vivo in mice. J. Immunol. 159:379-382.
23. Emson, C.L., S.E. Bell, A. Jones, W. Wisden, and A.N. McKenzie. 1998. Interleukin (IL)-4-independent induction of immunoglobulin (Ig)E, and perturbation of T cell development in transgenic mice expressing IL-13. J. Exp. Med. 188:399-404.
24. Finkelman, F.D., S.C. Morris, T. Orekhova, M. Mori, D. Donaldson, S.L. Reiner, N.L. Reilly, L. Schopf, and J.F. Urban, Jr. 2000. Stat6 regulation of in vivo IL-4 responses. J. Immunol. 164:2303-2310.
25. Schindler, U., P. Wu, M. Rothe, M. Brasseur, and S.L. McKnight. 1995. Components of a Stat recognition code: evidence for two layers of molecular selectivity. Immunity. 2:689-697.
26. Matsukawa, A., C.M. Hogaboam, N.W. Lukacs, P.M. Lincoln, H.L. Evanoff, R.M. Strieter, and S.L. Kunkel. 2000. Expression and contribution of endogenous IL-13 in an experimental model of sepsis. J. Immunol. 164:2738-2744.
27. Haque, S.J., P. Harbor, M. Tabrizi, T. Yi, and B.R. Williams. 1998. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction. J. Biol. Chem. 273:33893-33896.
28. Kawakami, K., J. Taguchi, T. Murata, and R.K. Puri. 2001. The interleukin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway. Blood. 97:2673-2679.
29. von der Weid, T., M. Kopf, G. Kohler, and J. Langhorne. 1994. The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice. Eur. J. Immunol. 24:2285-2293.
30. Lai, Y.H., and T.R. Mosmann. 1999. Mouse IL-13 enhances antibody production in vivo and acts directly on B cells in vitro to increase survival and hence antibody production. J. Immunol. 162:78-87.
31. McKenzie, G.J., C.L. Emson, S.E. Bell, S. Anderson, P. Fallon, G. Zurawski, R. Murray, R. Grencis, and A.N. McKenzie. 1998. Impaired development of Th2 cells in IL-13-deficient mice. Immunity. 9:423-432.
32. Oswald, I.P., R.T. Gazzinelli, A. Sher, and S.L. James. 1992. IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. J. Immunol. 148:3578-3582.
33. Takeda, K., M. Kamanaka, T. Tanaka, T. Kishimoto, and S. Akira. 1996. Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. J. Immunol. 157:3220-3222.
34. Sato, T.A., M.B. Widmer, F.D. Finkelman, H. Madani, C.A. Jacobs, K.H. Grabstein, and C.R. Maliszewski. 1993. Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo. J. Immunol. 150:2717-2723.
35. Fernandez-Botran, R., and E.S. Vitetta. 1991. Evidence that natural murine soluble interleukin 4 receptors may act as transport proteins. J. Exp. Med. 174:673-681.
36. Chiaramonte, M.G., D.D. Donaldson, A.W. Cheever, and T.A. Wynn. 1999. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J. Clin. Invest. 104:777-785.
37. Bost, K., R. Holton, T. Cain, and J. Clements. 1996. In vivo treatment with anti-interleukin-13 antibodies significantly reduces the humoral immune response against an oral immunogen in mice. Immunology. 87:633-641.
38. Chiaramonte, M.G., M. Mentink-Kane, B.A. Jacobson, A.W. Cheeves, M.J. Whitters, M.E.P. Goad, A. Wong, M. Collins, D.D. Donaldson, M.J. Gruby, et al. 2003. Regulation and function of the interleukin 13 receptor α 2 during T helper cell type 2-dominant immune response. J. Exp. Med. 197:687-701.